Aetna Inc. (AET) Shares Sold by Sumitomo Mitsui Trust Holdings Inc.
Sumitomo Mitsui Trust Holdings Inc. lowered its stake in shares of Aetna Inc. (NYSE:AET) by 0.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,016,220 shares of the company’s stock after selling 8,881 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about 0.31% of Aetna worth $161,589,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in the stock. Bruderman Asset Management LLC bought a new position in shares of Aetna during the 2nd quarter worth about $106,000. Lloyds Banking Group plc bought a new position in shares of Aetna during the 3rd quarter worth about $106,000. Moisand Fitzgerald Tamayo LLC bought a new position in shares of Aetna during the 3rd quarter worth about $116,000. Liberty Capital Management Inc. increased its stake in Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock valued at $144,000 after acquiring an additional 629 shares during the period. Finally, Westside Investment Management Inc. increased its stake in Aetna by 53.5% in the second quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock valued at $177,000 after acquiring an additional 400 shares during the period. 90.93% of the stock is owned by institutional investors and hedge funds.
Shares of Aetna Inc. (AET) traded down $1.19 during trading on Wednesday, hitting $171.83. 1,429,000 shares of the company traded hands, compared to its average volume of 2,441,657. The company has a market cap of $56,421.82, a price-to-earnings ratio of 16.95, a PEG ratio of 1.58 and a beta of 0.61. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 0.52. Aetna Inc. has a 12 month low of $116.04 and a 12 month high of $184.98.
Aetna (NYSE:AET) last posted its earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, topping the consensus estimate of $2.06 by $0.39. The business had revenue of $14.99 billion for the quarter, compared to the consensus estimate of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The firm’s revenue was down 5.0% compared to the same quarter last year. During the same period last year, the company earned $2.07 EPS. equities research analysts predict that Aetna Inc. will post 9.78 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Thursday, October 12th were paid a $0.50 dividend. The ex-dividend date was Wednesday, October 11th. This represents a $2.00 annualized dividend and a dividend yield of 1.16%. Aetna’s dividend payout ratio is currently 37.04%.
In other Aetna news, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction on Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the sale, the president now owns 64,261 shares in the company, valued at approximately $10,404,498.51. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the completion of the sale, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This news story was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/11/15/aetna-inc-aet-shares-sold-by-sumitomo-mitsui-trust-holdings-inc.html.
A number of equities analysts have commented on AET shares. Piper Jaffray Companies restated a “hold” rating and issued a $187.00 price target on shares of Aetna in a research report on Friday, November 3rd. Raymond James Financial, Inc. upgraded shares of Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 price target on the stock in a research report on Friday, November 3rd. Credit Suisse Group began coverage on shares of Aetna in a research report on Thursday, November 2nd. They issued a “neutral” rating and a $174.00 price target on the stock. Zacks Investment Research lowered shares of Aetna from a “buy” rating to a “hold” rating in a research report on Thursday, November 2nd. Finally, Citigroup Inc. increased their price objective on shares of Aetna from $183.00 to $197.00 and gave the company a “buy” rating in a report on Thursday, November 2nd. Eleven research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $172.36.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.